newsfilter
← Latest News
GlobeNewswire·

Statera Biopharma, Inc. Announces Institutional Review Board Approves Study of STAT-205 for Acute COVID-19

Researchers at Loma Linda University Health to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205 FORT COLLINS, Colo., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ:STAB), a leading biopharmaceutical company creating ne